MAGA law group fights to expose how Biden's DEI agenda may have tainted life-saving organ transplants
MAGA law group America First Legal is suing a number of federal health agencies to obtain documents related to the nation's organ transplant system.
Specifically, they're targeting the Department of Health and Human Services, the Centers for Medicare and Medicaid Services and the Health Resources Services Administration, in an attempt to compel them to turn over documents related to the Organ Procurement and Transplantation Network (OPTN).
In April 2023, AFL filed a Freedom of Information Act (FOIA) request seeking documents relevant to the Biden administration's efforts to infuse DEI into the organ transplant system. However, to date, AFL says it has not received any of the requested information and, as a result, decided to sue in an effort to compel the release of it.
"The Biden Administration infected the federal government with 'equity,' replacing traditional principles of fairness and need with race-conscious criteria," said America First Legal Counsel Will Scolinos. "AFL is determined to uncover the complete scope of Biden-era DEI policies and will continue to take decisive action to restore colorblind healthcare."
Just days after taking office in 2021, former President Joe Biden signed Executive Order 13985, directing all federal agencies to conduct "Equity Assessments" to determine whether "underserved communities and their members" faced systemic barriers to accessing federal programs. The order also required each agency to develop an action plan to address those barriers.
As part of this effort, in December 2021, CMS issued a request to the public for comments on how the agency could "Advance Equity and Reduce Disparities in Organ Transplantation."
"CMS is focused on identifying potential system-wide improvements that would increase organ donations, improve transplants, enhance the quality of care in dialysis facilities, increase access to dialysis services, and advance equity in organ donation and transplantation," the agency said at the time.
"Communities of color have much higher rates of high blood pressure, diabetes, obesity, and heart disease, all of which increase the risk for kidney disease. Black Americans are almost four times more likely, and Latinos are 1.3 times more likely, to have kidney failure compared to White Americans. Despite the higher risk, data shows that Black and Latino patients on dialysis are less likely to be placed on the transplant waitlist and have a lower likelihood of transplantation. Because of these stark inequities, CMS' [Request For Information] asks the public for specific ideas on advancing equity within the organ transplantation system."
Meanwhile, several weeks later, the HRSA announced that the "labeling of race and ethnicity information for organ donors" would "change on a number of data reports available on the Organ Procurement and Transplantation Network (OPTN) website." According to the HRSA, the move made the data "clearer, more consistent and easier for users to interpret," and did not impact the manner in which data is collected. OPTN collects and manages data pertaining to the patient waiting list, organ donation, matching and transplantation in the U.S.
HRSA also announced a "modernization initiative" for OPTN around the same time, which included plans to strengthen "equity, and performance in the organ donation and transplantation system."
In its lawsuit, AFL chronicled a series of delays, non-responses and incomplete communications following its April 2023 FOIA request. AFL is hoping to obtain a judge's order requiring the release of the records it is seeking, as well as an index of any withheld material and explanations for why it could not be provided.
"The last administration's pervasive directives requiring consideration of immutable characteristics like race, color, and ethnicity — to make healthcare more 'equitable' — should concern all Americans," Scolinos said Tuesday. "AFL is determined to uncover the complete scope of Biden-era DEI policies and will continue to take decisive action to restore colorblind healthcare."
HHS declined to comment on AFL's lawsuit.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Trump orders a 35% tariff for goods from Canada, citing a lack of cooperation on illicit drugs
WASHINGTON (AP) — U.S. President Donald Trump has raised the tariff rate on U.S. imports from Canada to 35% from 25%, effective Friday. The announcement from the White House late Thursday said Canada had failed to 'do more to arrest, seize, traffickers, criminals at large, and illicit drugs.' Trump earlier had threatened to impose the higher tariff on Canada if no deal was reached by Friday, his deadline for reaching trade agreements with dozens of countries. Canada was not included in Trump's updated list of tariff rates on other countries announced late Thursday. Those import duties are due to take effect on Aug. 7. Prime Minister Mark Carney had tempered expectations, saying Ottawa will only agree to a deal 'if there's one on the table that is in the best interests of Canadians.' In a subsequent statement, released just after midnight, he said he was disappointed by the actions and that 'Canada accounts for only 1% of U.S. fentanyl imports and has been working intensively to further reduce these volumes.' He added that some industries — including lumber, steel, aluminum and automobiles — will be harder hit, but that the government will try to minimize the impact and protect Canadian jobs.
Yahoo
13 minutes ago
- Yahoo
'Daily Show' Calls 'Bulls**t' On Right-Wing Defense Of Sydney Sweeney Ad
'Daily Show' correspondent Desi Lydic on Thursday hit back at right-wing media figures over their reaction to backlash against Sydney Sweeney's controversial American Eagle ad. Lydic referred to those accusing the ad — which declares that the blonde, blue-eyed 'Euphoria' star has 'great jeans' — of being a 'racist dog whistle' before turning to clips of conservative media figures who, in turn, reacted with a 'dog megaphone.' The supercut featured ex-Fox News host Megyn Kelly, who took aim at so-called 'nonsense where you are not allowed to ever celebrate' someone who is white and blonde with blue eyes. Fox News' Greg Gutfeld, in a separate clip from 'The Five,' imagined the backlash was due to Sweeney not being 'a plus-size swim model on the cover of Sports Illustrated' or a 'male prom queen.' Lydic — who mocked Kelly and Gutfeld for gushing over how Sweeney's body appears in the ad — swiftly advised right-wingers to 'calm down.' 'This is such bullshit, blonde women have had constant representation, OK? Inentertainment, infashion, in letter turning,' Lydic said. She proceeded to slam conservatives, 'It's not that they want to see more white women, it's that they want to see none of anyone else. For a story about boobs, it sure has a hell of a lot of assholes.' Her comments arrived moments after she called out Kelly's sudden change in tone toward Sweeney, who she once suggested to be the 'new toast of the town' due to her 'amazing breasts' roughly one month ago. The 'Daily Show' correspondent pointed to several instances where Kelly ripped famous women for their looks. 'Yeah, yeah! That's right, women, you listen to Megyn Kelly and hide your sexuality unless your body makes liberals mad, in which case it's a kickass body! Hell yeah! Go girl!' Lydic quipped. 'You motorboat those liberals here but not so much that it threatens Megyn or so help me God, she will destroy you ho bags!' Check out more of Lydic's Thursday monologue on 'The Daily Show.' Related... 'Daily Show' Uncovers The Brutal Reason Behind Trump's Scotland Trip Stephen Colbert Trolls 'Fart Machine' Trump After Don Jr.'s Uncomfortable Compliment Seth Meyers Spots The Exact Moment Trump Looked 'Actually Broken'
Medscape
15 minutes ago
- Medscape
PCPs Guide to Prescribing Blood Thinners for AF
As a primary care physician (PCP), you're often the first healthcare professional that will identify cardiac issues, including atrial fibrillation (AF). Individuals with AF face a fivefold risk for stroke. Therefore, these patients are often prescribed blood-thinning medications (anticoagulants) to slow blood clotting, according to the American Society of Hematology (ASH). Up to six million Americans have AF, the risk for which increases with age. The ASH says there are 450,000 hospitalizations each year because of AF. It's very important to check on your patient's response within the first few months of taking blood thinners. In fact, patients with AF who took low doses of oral anticoagulants experienced a higher incidence of bleeding episodes during the first 3 months of treatment, according to a study published in Blood Advances . When Should PCPs Prescribe Anticoagulants? PCPs should consider prescribing oral anticoagulants when they are the principal caregivers for patients with AF, acute deep venous thrombosis, or acute pulmonary embolism, according to R. Michael Benitez, MD, a cardiologist at the University of Maryland Medical Center and a professor of medicine in the Division of Cardiovascular Medicine at the University of Maryland School of Medicine in Baltimore. The decision to prescribe an oral anticoagulant must be based upon the patient's risk without anticoagulation weighed in context with the patient's risk for significant bleeding, he said. How Can Physicians Best Communicate the Rationale for Anticoagulant Therapy? When describing AF, PCPs can explain to patients that the upper chamber of heart is 'wiggling' and not effectively contracting and when blood is not being effectively moved forward, it tends to clot, said Benitez. Physicians can also share that a clot as small as 2 mm is large enough to cause a major stroke if it were to break loose from the inside of the top chamber and be pumped with the blood to the brain, suggested the cardiologist. 'The oral anticoagulant greatly reduces the risk of the formation of these blood clots and subsequent stroke,' Benitez said. 'Stroke is a terrible event that, if survived, often changes a patient's life permanently and significantly. In the setting of atrial fibrillation, anticoagulation greatly reduces the patient's risk of stroke.' Regarding deep venous thrombosis, physicians can explain that a blood clot in the leg veins could break loose and be pumped through the right side of the heart to the lungs. 'This event, pulmonary embolism, can cause critical illness or even death; the risk can be greatly reduced through the use of oral anticoagulants,' said Benitez. What Are Important Directives Regarding Usage? PCPs should stress that daily use is critical to the success of the drug in preventing stroke. 'In the case of the new direct oral anticoagulants, such as apixaban or rivaroxaban, the drugs both work very quickly but also wear off very quickly,' said Benitez. 'This means that even missing just 2-3 days is enough for the blood to again clot normally. It is essential that the drugs be taken daily to prevent stroke.' In the case of warfarin, the effect of the drug is more prolonged. While missing a single dose is unlikely to markedly change the degree of anticoagulation, it's still best to remind patients not to miss doses and take this daily as prescribed, according to Benitez. What Side Effects Should Be Discussed? It is extremely important with warfarin — and to a lesser degree with direct oral anticoagulants — to always make certain that there is no drug-drug interaction that might affect the degree of anticoagulation when new medications are introduced, such as antibiotics, said Benitez. Other side effects to bring to a patients' attention are minor bleeding (such as gum bleeding with dental flossing) or nose bleeds that stop easily, which don't require immediate medical attention. However, your patients should self-monitor bleeding episodes and know a course of action if injured. 'If bleeding will not readily stop then medical attention is needed, and patients who incur major injury or trauma are likely to be taken to an emergency facility where it is important for the staff caring for them to know what anticoagulant they are taking, the dose, and when they last took it,' Benitez said. 'Reversal agents are now available to normalize blood clotting.' Your patients may be concerned with food that could interact with these medications. Benitez said there are no significant food interactions or dietary restrictions. But when prescribing warfarin, some nutritional guidance is warranted. 'With warfarin, which is a vitamin K antagonist, it is essential that the patient limit their intake of food containing vitamin K, as it is essentially an antidote or reversal agent for the anticoagulant,' he said. Some sources of vitamin K are well-known, such as leafy vegetables like spinach, kale, and other greens. However, there are many other dietary sources rich in vitamin K that may not be as obvious, such as cauliflower and soy products, Benitez said. 'It is important for the patient to familiarize themselves with vitamin K-containing foods and to keep the intake of them low and steady from day to day if they are taking warfarin,' he said.
